Gadolinium Market
The market for Gadolinium was estimated at $318 million in 2024; it is anticipated to increase to $569 million by 2030, with projections indicating growth to around $924 million by 2035.
Global Gadolinium Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2025 - 2034
The Gadolinium industry revenue is expected to be around $349.9 million in 2025 and expected to showcase growth with 10.2% CAGR between 2025 and 2034. The steady expansion of the Gadolinium market is due to its flexibility in uses and ongoing advancements in associated technologies. Gadoliniums unique characteristics have established it as a component across different industries leading to its continuous significance in the worldwide market. This upward trend in growth is influenced by factors like the expanding use of Gadolinium in industries the rising need, for healthcare applications benefiting from its imaging capabilities and the launch of more effective products. Considering the part that Gadolinium plays in significant technological progressions. Both existing and upcoming ones. Which have contributed to its ongoing importance is also important.
Rare earth metal gadolinium is known for its magnetic and nuclear characteristics as showcased in the periodic table of elements and has become crucial in various fields such as medical imaging technology and electronic manufacturing among others besides being utilized in creating efficient lighting solutions and serving as a neutron absorber even outside its traditional applications, in nuclear reactors.
Market Key Insights
- The Gadolinium market is projected to grow from $317.5 million in 2024 to $839 million in 2034. This represents a CAGR of 10.2%, reflecting rising demand across MRI Contrast Agents, Phosphors & Electronics and Neutron Radiography.
- Albemarle Corporation, Avantium, Alkane Resources Ltd are among the leading players in this market, shaping its competitive landscape.
- U.S. and China are the top markets within the Gadolinium market and are expected to observe the growth CAGR of 7.4% to 10.7% between 2024 and 2030.
- Emerging markets including Brazil, Indonesia and South Africa are expected to observe highest growth with CAGR ranging between 9.8% to 12.8%.
- Transition like The Advent of GadoliniumBased Contrast Agents is expected to add $27 million to the Gadolinium market growth by 2030.
- The Gadolinium market is set to add $521 million between 2024 and 2034, with manufacturer targeting Therapeutic Use & Industrial Use Applications projected to gain a larger market share.
- With Increasing use in medical imaging, and Advancements in nuclear reactor technology, Gadolinium market to expand 164% between 2024 and 2034.